Navigation Links
Bayer Diabetes Care Names 'Walk In Nick's Shoes' (W.I.N.S.) Sweepstakes Grand Prize Winners
Date:10/30/2008

y 2006, Bayer Diabetes Care acquired Metrika Inc., maker and manufacturer of A1CNow+, a meter-based diabetes monitoring system for measurement of A1C (glycated hemoglobin) an important indicator of long term blood sugar control.

Bayer HealthCare, Diabetes Care global headquarters is located in Tarrytown, New York, in the United States and operates as part of Bayer HealthCare LLC, a member of the worldwide Bayer HealthCare group. http://www.bayerdiabetes.com/us

Bayer HealthCare

Bayer HealthCare, a subsidiary of Bayer AG, is one of the world's leading, innovative companies in the healthcare and medical products industry and is based in Leverkusen, Germany. The company combines the global activities of the Animal Health, Consumer Care, Diabetes Care and Pharmaceuticals divisions. The pharmaceuticals business operates under the name Bayer Schering Pharma AG. Bayer HealthCare's aim is to discover and manufacture products that will improve human and animal health worldwide.

This news release contains forward-looking statements based on current assumptions and forecasts made by Bayer Group management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in our public reports filed with the Frankfurt Stock Exchange and with the U.S. Securities and Exchange Commission (including our Form 20-F). The company assumes no liability whatsoever to update these forward-looking statements or to inform them to future events or developments.


'/>"/>
SOURCE Bayer Diabetes Care
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. IVCC launches groundbreaking insecticide projects with Bayer and Syngenta
2. AUDIO from Medialink and Bayer: Simple, Focused Ways to Boost Womens Health
3. Bayer HealthCare Cleared to Acquire Citracal(R)
4. Genzyme and Bayer Schering Pharma AG, Germany to Present New Data on Alemtuzumab in Multiple Sclerosis at ECTRIMS
5. Bayer Foundation Grant Creates Graduate Engineering Fellowship at University of Houston
6. AUDIO from Medialink and Bayer: Is Your Pain Reliever Undermining Your Aspirin Therapy?
7. Bayer Temporarily Suspends Global Trasylol(R) Marketing
8. AUDIO from Medialink and Bayer: Lifesaving Benefits of Low-Dose Aspirin Therapy Maintained with Naproxen Sodium
9. Bayer Plants Trees With Chartiers Valley Intermediate School Students, Provides Free Environmental Education Materials
10. Bayer Awards Making Science Make Sense Grant to Girl Scouts
11. Bayer HealthCare Pharmaceuticals and MedAssets Supply Chain Systems Sign a Three-Year Agreement for Magnevist(R) Magnetic Resonance Contrast Media
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Patent Expiries of Blockbuster Antibiotics Will Fuel a Decline of More Than 15 Percent in the Community-Acquired Pneumonia Drug Market 2Pivotal Trial Data Demonstrate NeuroPace RNS(R) System Reduced Seizures in People With Epilepsy 2Pivotal Trial Data Demonstrate NeuroPace RNS(R) System Reduced Seizures in People With Epilepsy 3Pivotal Trial Data Demonstrate NeuroPace RNS(R) System Reduced Seizures in People With Epilepsy 4Trubion and Facet Biotech Announce Presentation of Positive TRU-016 Data at the 2009 ASH Annual Meeting 2Trubion and Facet Biotech Announce Presentation of Positive TRU-016 Data at the 2009 ASH Annual Meeting 3Trubion and Facet Biotech Announce Presentation of Positive TRU-016 Data at the 2009 ASH Annual Meeting 4Trubion and Facet Biotech Announce Presentation of Positive TRU-016 Data at the 2009 ASH Annual Meeting 5Trubion and Facet Biotech Announce Presentation of Positive TRU-016 Data at the 2009 ASH Annual Meeting 6QLT Announces Second Quarter Results for 2009 52895 1QLT Announces Second Quarter Results for 2009 52895 2QLT Announces Second Quarter Results for 2009 52895 3QLT Announces Second Quarter Results for 2009 52895 4QLT Announces Second Quarter Results for 2009 52895 5QLT Announces Second Quarter Results for 2009 52895 6QLT Announces Second Quarter Results for 2009 52895 7QLT Announces Second Quarter Results for 2009 52895 8QLT Announces Second Quarter Results for 2009 52895 9QLT Announces Second Quarter Results for 2009 52895 10QLT Announces Second Quarter Results for 2009 52895 11QLT Announces Second Quarter Results for 2009 52895 12QLT Announces Second Quarter Results for 2009 52895 13QLT Announces Second Quarter Results for 2009 52895 14QLT Announces Second Quarter Results for 2009 52895 15QLT Announces Second Quarter Results for 2009 52895 16QLT Announces Second Quarter Results for 2009 52895 17NeoGenomics Reports Second Quarter 2009 Results 13224 1NeoGenomics Reports Second Quarter 2009 Results 13224 2NeoGenomics Reports Second Quarter 2009 Results 13224 3NeoGenomics Reports Second Quarter 2009 Results 13224 4NeoGenomics Reports Second Quarter 2009 Results 13224 5NeoGenomics Reports Second Quarter 2009 Results 13224 6NeoGenomics Reports Second Quarter 2009 Results 13224 7NeoGenomics Reports Second Quarter 2009 Results 13224 8NeoGenomics Reports Second Quarter 2009 Results 13224 9GeneGo Awarded NIH Grant to Develop Pharmacogenomics Software Suite 52890 1GeneGo Awarded NIH Grant to Develop Pharmacogenomics Software Suite 52890 2